Random

Health

The image shows the tau proteins associated with Alzheimer's disease.

·June 19, 2013·3 min read

New Alzheimer’s Research Suggests Possible Cause: The Interaction of Proteins in the Brain

Researchers discover by looking at amyloid-beta and tau independently that the interaction between the proteins could be the key to the cognitive decline associated with Alzheimer's disease. As the interaction between the two proteins increased, the progression of Alzheimer's worsened.

The image shows the outline of a human head infront of a blue background which is supposed to resemble neurons.

Featured Neurology

·April 14, 2014·2 min read

A Single Switch Dictates Severity of Epileptic Seizures

Researchers claim to have identified a switch in the brain of people with epilepsy which dictates whether their seizures will be mild or lead to a loss of consciousness.

This shows a woman looking out of a window

Featured Neuroscience Psychology

·April 26, 2020·3 min read

COVID-19: The downside of social distancing

Social distancing, while essential for public health during the coronavirus pandemic, thwarts the human impulse to draw together in times of danger.

The image shows the areas of the brain affected by schizophrenia.

Featured Psychology

·June 17, 2013·2 min read

Psychiatric Disorders Linked to a Protein Involved in the Formation of Long-Term Memories

Researchers have discovered a neural pathway in which the brain controls a specific molecule, connected to bipolar disorder and schizophrenia which is also critical to the formation of long term memory.

The image shows a child with ASD identifying words from a flash card.

Autism Featured

·March 4, 2013·3 min read

Speech Emerges in Children with Autism and Severe Language Delay at Greater Rate Than Previously Thought

A new study reveals 70 percent of children diagnosed with autism spectrum disorders, and who have a history of severe language delay, achieved fluent speech by the age of eight.

Brain Cancer Featured Genetics Neurology Neuroscience Open Neuroscience Articles

·May 1, 2020·4 min read

New targets for childhood brain tumors identified

Neurons and immune cells work together to promote tumor growth in neurofibromatosis type 1.

Featured Neuroscience Open Neuroscience Articles

·June 3, 2021·4 min read

The Dream Team: Drug Duo May Cure COVID-19

Two medications commonly used to treat inflammation and HIV infection have been repurposed in the fight against COVID-19. Researchers found combined cepharanthine/nelfinavir therapy can hasten the clearance of coronavirus infection from a person's lungs in as little as 4.9 days. Cepharanthine hindered the entry of SARS_CoV_2 into cells, preventing the virus from binding to a protein on the cell membrane it uses as a gateway. Nelfinavir prevented the virus from replicating inside cells by inhibiting a protein the virus relies on for replication.